Vivien Dupont

机构：The Lymphoma Academic Research Organisation

发表论文 11 篇 · 总被引 44 次 · h-index 4

代表论文

• Outcome of patients with large B-cell lymphoma treated with tafasitamab plus lenalidomide either before or after CAR T-cell therapy (2024 · Blood Advances · 被引 16)
• Outcomes of patients with relapsed or refractory primary mediastinal B‐cell lymphoma treated with anti‐CD19 CAR‐T cells: CARTHYM, a study from the French national DESCAR‐T registry (2025 · HemaSphere · 被引 15)
• Invasive fungal infections after CD19 chimeric antigen receptor T-cell therapy for B-cell lymphoma: a Lymphoma study association study from the DESCAR-T (Dispositif d’Enregistrement et Suivi des patients traités par CAR-T cells) registry (2025 · Clinical Microbiology and Infection · 被引 8)
• TRANSCAR: real-world outcomes of CD19 CAR T-cell therapy in relapsed/refractory transformed indolent lymphomas (2025 · Blood Advances · 被引 4)
• Outcomes and treatment patterns of patients with primary mediastinal b-cell lymphoma after CAR-t cell therapy failure : A descar-t analysis (2025 · Blood · 被引 1)
• Outcomes and salvage strategies for large B‐cell lymphoma progressing after second‐line CAR T‐cell therapy: A DESCAR‐T study from the LYSA group (2026 · HemaSphere)